| A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies S Chatterjee, M Bhattacharya, S Nag, K Dhama, C Chakraborty Viruses 15 (1), 167, 2023 | 113 | 2023 |
| D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity M Bhattacharya, S Chatterjee, AR Sharma, G Agoramoorthy, ... Applied microbiology and biotechnology, 1-11, 2021 | 40 | 2021 |
| Delta variant (B. 1.617. 2) of SARS-CoV-2: Current understanding of infection, transmission, immune escape, and mutational landscape M Bhattacharya, S Chatterjee, AR Sharma, SS Lee, C Chakraborty Folia Microbiologica 68 (1), 17-28, 2023 | 23 | 2023 |
| Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole … M Bhattacharya, S Chatterjee, S Nag, K Dhama, C Chakraborty Travel Medicine and Infectious Disease, 102481, 2022 | 22 | 2022 |
| Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical Perspective M Bhattacharya, S Chatterjee, B Mallik, AR Sharma, C Chakraborty Vaccines 10 (10), 1612, 2022 | 15 | 2022 |
| Can artificial intelligence-strengthened ChatGPT or other large language models transform nucleic acid research? S Chatterjee, M Bhattacharya, SS Lee, C Chakraborty Molecular Therapy-Nucleic Acids 33, 205-207, 2023 | 13 | 2023 |
| Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern? S Chatterjee, M Bhattacharya, K Dhama, SS Lee, C Chakraborty Molecular Therapy-Nucleic Acids 32, 263-266, 2023 | 12 | 2023 |
| Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update M Bhattacharya, S Chatterjee, SS Lee, C Chakraborty International Journal of Biological Macromolecules 229, 70-80, 2023 | 10 | 2023 |
| Relooking the monkeypox virus during this present outbreak: epidemiology to therapeutics and vaccines S Chatterjee, AR Sharma, M Bhattacharya, K Dhama, SS Lee, ... European Review for Medical and Pharmacological Sciences 26 (16), 5991-6003, 2022 | 6 | 2022 |
| Can the RBD mutation R346X provide an additional fitness to the “variant soup,” including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance? S Chatterjee, M Bhattacharya, K Dhama, SS Lee, C Chakraborty Molecular Therapy-Nucleic Acids 32, 61-63, 2023 | 5 | 2023 |
| ChatGPT and large language models in orthopedics: from education and surgery to research S Chatterjee, M Bhattacharya, S Pal, SS Lee, C Chakraborty Journal of Experimental Orthopaedics 10 (1), 128, 2023 | 4 | 2023 |
| Bioactivity, Molecular Mechanism, and Targeted Delivery of Flavonoids for Bone Loss AR Sharma, YH Lee, A Bat-Ulzii, S Chatterjee, M Bhattacharya, ... Nutrients 15 (4), 919, 2023 | 4 | 2023 |
| Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants M Bhattacharya, S Chatterjee, SS Lee, K Dhama, C Chakraborty Drug Resistance Updates, 101008, 2023 | 3 | 2023 |
| Structural Landscape of nsp Coding Genomic Regions of SARS-CoV-2-ssRNA Genome: A Structural Genomics Approach Toward Identification of Druggable Genome, Ligand-Binding Pockets … C Chakraborty, M Bhattacharya, AR Sharma, S Chatterjee, ... Molecular Biotechnology, 1-22, 2022 | 3 | 2022 |
| Molnupiravir’s mechanism of action drives “error catastrophe” in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virus S Chatterjee, M Bhattacharya, K Dhama, SS Lee, C Chakraborty Molecular Therapy-Nucleic Acids 33, 49-52, 2023 | 2 | 2023 |
| Advances in Nanozymes as a Paradigm for Viral Diagnostics and Therapy G Sharma, S Chatterjee, C Chakraborty, JC Kim Pharmacological Reviews 75 (4), 739-757, 2023 | 2 | 2023 |
| The D614G mutation helps to increase the transmissibility and reduce the virulence of SARS-CoV-2 variants through natural selection C Chakraborty, S Chatterjee, M Bhattacharya, H Chopra, P Bhattacharya, ... International Journal of Surgery 109 (2), 171-174, 2023 | 2 | 2023 |
| Different cellular barriers to RNA therapeutics and strategies to overcome S Chatterjee, M Bhattacharya, G Agoramoorthy, C Chakraborty International Journal of Surgery, 10.1097, 2023 | 1 | 2023 |
| Current status in clinical advancement of RNA therapeutics–Correspondence S Chatterjee, M Bhattacharya, G Agoramoorthy, C Chakraborty International Journal of Surgery, 106996, 2022 | 1 | 2022 |
| Current landscape of long COVID clinical trials M Bhattacharya, S Chatterjee, S Saxena, SS Nandi, SS Lee, ... International Immunopharmacology 132, 111930, 2024 | | 2024 |
Chiranjib Chakraborty, Ph.DProfessor of Biotechnology, School of Life Science and Biotechnology, Adamas University, IndiaVerified email at adamasuniversity.ac.in
